4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacy
摘要:
The lead optimization of a series of potent azaindole IKK2 inhibitors is described. Optimization of the human whole blood activity and selectivity over IKK1 in parallel led to the discovery of 16, a potent and selective IKK2 inhibitor showing good efficacy in a rat model of neutrophil activation. (c) 2012 Elsevier Ltd. All rights reserved.
[EN] BENZPYRAZOL DERIVATIVES AS INHIBITORS OF PI3 KINASES<br/>[FR] DÉRIVÉS DE BENZPYRAZOLE EN TANT QU'INHIBITEURS DE P13 KINASES
申请人:GLAXO GROUP LTD
公开号:WO2009147188A1
公开(公告)日:2009-12-10
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds according to formula (I):
and salts thereof.
The compounds of the invention are inhibitors of kinase activity, in particular IKK2 activity.
PYRROLO[2,3-B]PYRIDIN-4-YL-BENZENESULFONAMIDE COMPOUNDS AS 1KK2 INHIBITORS
申请人:Bamborough Paul
公开号:US20100035917A1
公开(公告)日:2010-02-11
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds according to Formula (1) and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular 1KK2 activity.
BENZPYRAZOL DERIVATIVES AS INHIBITORS OF PI3 KINASES
申请人:Baldwin Ian Robert
公开号:US20110178063A1
公开(公告)日:2011-07-21
The invention is directed to certain novel compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.
Benzpyrazol derivatives as inhibitors of PI3 kinases
申请人:Baldwin Ian Robert
公开号:US08658635B2
公开(公告)日:2014-02-25
The invention is directed to certain novel compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.